Regulatory role of microRNA‑185 in the recovery process after ankle fracture

Sun,Deping; Liu,Juntao; Shi,Qingpeng; Mu,Haibo; Zhou,Dongsheng

doi:10.3892/etm.2018.6534

Regulatory role of microRNA‑185 in the recovery process after ankle fracture

Authors:
- Deping Sun
- Juntao Liu
- Qingpeng Shi
- Haibo Mu
- Dongsheng Zhou
View Affiliations

Affiliations: Department of Orthopedics, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China, Department of Orthopedic Trauma, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264000, P.R. China
Published online on: July 27, 2018 https://doi.org/10.3892/etm.2018.6534
Pages: 3261-3267

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the expression of microRNA (miR)‑185 in the bone and blood tissues following ankle fracture, and its regulatory mechanism in the ankle fracture recovery process. In total, 28 patients with ankle fractures were included, including 15 cases receiving surgical treatment within 1‑7 days after fracture, and 13 cases receiving surgery within 8‑14 days after fracture. Reverse transcription‑quantitative polymerase chain reaction was performed to detect the mRNA expression levels. Western blot analysis and ELISA were used to determine the protein expression levels. Bioinformatics analysis and dual‑luciferase reporter assay were applied to predict and confirm the upstream regulator of tumor growth factor (TGF)‑β1. An MTT assay was performed to assess the cell proliferation. Compared with the 1‑7‑day surgery group, the mRNA and protein expression levels of TGF‑β1 were significantly elevated, while the expression levels of miR‑185 were significantly declined in the bone and blood tissues in the 8‑14‑day surgery group. Bioinformatics analysis and dual‑luciferase reporter assay predicted and confirmed that TGF‑β1 was the direct target gene of miR‑185. Moreover, upregulated expression of miR‑185 significantly decreased the protein expression levels of TGF‑β1 and reduced the proliferating activity of hFOB1.19 cells. Within two weeks after ankle fracture, the expression levels of TGF‑β1 are significantly upregulated in the bone and blood tissues, which may have been associated with the downregulated expression of miR‑185. miR‑185 may modulate TGF‑β1 to regulate the recovery of ankle fracture. These findings may contribute to the understanding of the biological functions and effects of miRNA‑185 and TGF‑β1 in ankle fractures.

View Figures

View References

1	Court-Brown CM, McBirnie J and Wilson G: Adult ankle fractures-an increasing problem? Acta Orthop Scand. 69:43–47. 1998. View Article : Google Scholar : PubMed/NCBI
2	Mandell JC, Khurana B and Smith SE: Stress fractures of the foot and ankle, part 1: Biomechanics of bone and principles of imaging and treatment. Skeletal Radiol. 46:1021–1029. 2017. View Article : Google Scholar : PubMed/NCBI
3	Kang P, Tang B, Liu Y, Liu X, Shen Y, Liu Z, Yang H and Zhang L: Profile and procedures for fractures among 1323 fracture patients from the 2010 Yushu earthquake, China. Am J Emerg Med. 34:2132–2139. 2016. View Article : Google Scholar : PubMed/NCBI
4	Zou L, Zhang G, Liu L, Chen C, Cao X and Cai J: A MicroRNA-124 polymorphism is associated with fracture healing via modulating BMP6 expression. Cell Physiol Biochem. 41:2161–2170. 2017. View Article : Google Scholar : PubMed/NCBI
5	Gennari L, Bianciardi S and Merlotti D: MicroRNAs in bone diseases. Osteoporos Int. 28:1191–1213. 2017. View Article : Google Scholar : PubMed/NCBI
6	Huang HM, Li XL, Tu SQ, Chen XF, Lu CC and Jiang LH: Effects of roughly focused extracorporeal shock waves therapy on the expressions of bone morphogenetic protein-2 and osteoprotegerin in osteoporotic fracture in rats. Chin Med J (Engl). 129:2567–2575. 2016. View Article : Google Scholar : PubMed/NCBI
7	Hulth A: Current concepts of fracture healing. Clin Orthop Relat Res. 1–284. 1989.
8	Tatsuyama K, Maezawa Y, Baba H, Imamura Y and Fukuda M: Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur J Histochem. 44:269–278. 2000.PubMed/NCBI
9	Ma C, Wei F, Xia H, Liu H, Dong X, Zhang Y, Luo Q, Liu Y and Li Y: MicroRNA-10b mediates TGF-β1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition. Int J Oncol. 50:1739–1748. 2017. View Article : Google Scholar : PubMed/NCBI
10	Sandbothe M, Buurman R, Reich N, Greiwe L, Vajen B, Gürlevik E, Schäffer V, Eilers M, Kühnel F, Vaquero A, et al: The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4. J Hepatol. 66:1012–1021. 2017. View Article : Google Scholar : PubMed/NCBI
11	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
12	Canalis E, McCarthy T and Centrella M: Growth factors and the regulation of bone remodeling. J Clin Invest. 81:277–281. 1988. View Article : Google Scholar : PubMed/NCBI
13	Beige J, Kreutz R and Rothermund L: Acute renal failure: Pathophysiology and clinical management. Dtsch Med Wochenschr. 132:2569–2578. 2007.(In German). View Article : Google Scholar : PubMed/NCBI
14	Joyce ME, Roberts AB, Sporn MB and Bolander ME: Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol. 110:2195–2207. 1990. View Article : Google Scholar : PubMed/NCBI
15	Centrella M, McCarthy TL and Canalis E: Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem. 262:2869–2874. 1987.PubMed/NCBI
16	Zhao X, Mohan R, Özcan S and Tang X: MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. J Biol Chem. 287:31155–31164. 2012. View Article : Google Scholar : PubMed/NCBI
17	Chen K and Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 8:93–103. 2007. View Article : Google Scholar : PubMed/NCBI
18	Bai W, Chen Y, Yang J, Niu P, Tian L and Gao A: Aberrant miRNA profiles associated with chronic benzene poisoning. Exp Mol Pathol. 96:426–430. 2014. View Article : Google Scholar : PubMed/NCBI
19	Kim JO, Song DW, Kwon EJ, Hong SE, Song HK, Min CK and Kim DH: miR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathways. PLoS One. 10:e01225092015. View Article : Google Scholar : PubMed/NCBI
20	Ma X, Shen D, Li H, Zhang Y, Lv X, Huang Q, Gao Y, Li X, Gu L, Xiu S, et al: MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma. Urol Oncol. 33:169.e1–e111. 2015. View Article : Google Scholar
21	Bao L, Fu X, Si M, Wang Y, Ma R, Ren X and Lv H: MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes. PLoS One. 10:e01160672015. View Article : Google Scholar : PubMed/NCBI
22	Fu P, Du F, Yao M, Lv K and Liu Y: MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells. Exp Ther Med. 8:1879–1883. 2014. View Article : Google Scholar : PubMed/NCBI
23	Wang R, Tian S, Wang HB, Chu DP, Cao JL, Xia HF and Ma X: MiR-185 is involved in human breast carcinogenesis by targeting Vegfa. FEBS Lett. 588:4438–4447. 2014. View Article : Google Scholar : PubMed/NCBI